June 16, 2026 · Form 4 insider transaction
Farrow Jeffrey S sold 14,396 shares of Tarsus Pharmaceuticals, Inc. at $60.95 per share, a transaction worth $877.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.